GO
Loading...

Novartis AG

More

  • Clank of America Monday, 21 Apr 2008 | 6:17 PM ET

    The Dow pulled back Monday after a weaker-than-expected profit report from Bank of America stirred concerns about the health of corporate earnings. What's the "Word on The Street?"

  • European Earnings: Novartis Profit Jumps 10% Monday, 21 Apr 2008 | 12:43 PM ET

    Drug maker Novartis reported a better-than-expected rise in first-quarter profit, thanks to strong vaccine sales, while quarterly sales at Nestle also beat expectations.

  • Stocks Close Mixed as Tech, Energy Gain Monday, 21 Apr 2008 | 12:39 PM ET

    Stocks close mixed as quarterly results from Bank of America and National City fueled worries about bank earnings, while energy and tech gained.

  • Week Ahead: The Big Test Friday, 18 Apr 2008 | 8:09 PM ET

    Whenever the stock market rushes full speed ahead, it is hard not to look for the big let-down. That could be the case in the week ahead... Major earnings reports, housing data, annual shareholder meetings, and Tuesday's Pennsylvania presidential primaries are what traders will be watching to see if the trend continues.

  • Bitter Pill? Friday, 18 Apr 2008 | 6:28 PM ET

    Was Pfizer's miss, a prescription for disaster in Big Pharma? Should you sell drug makers ahead of earnings next week?

  • Springtime for Pharma: A Big Week Ahead For Earnings Friday, 18 Apr 2008 | 12:01 PM ET

    The irreverent producers of "Squawk on the Street" who are stationed in the pod next to mine here at CNBC like to call it "Pharmapalooza." They're referring to weeks like the one coming up when nearly every big drug company reports earnings.

  • Johnson & Johnson's Earnings And Its Very "Taxing" Day Tuesday, 15 Apr 2008 | 3:56 PM ET
    Johnson & Johnson

    Dow component and healthcare conglomerate (drugs, consumer products, medical devices) Johnson & Johnson beat and boosted. That's Wall Street jargon for earnings coming in higher than expectations and the guidance for the rest of the year being raised. So, why did the stock go down?

  • For the week ending Friday, April 11, 2008 the US Markets ended the week in negative territory. There was not a lot of movement in the markets for most of the week, as the major indices traded on a mix of news including same store sales, record highs in oil, flight cancellations from major airlines, and disappointing first quarter results from Alcoa (AA). The markets tumbled on Friday on General Electric's (GE) disappointing earnings.

  • Meds, Mergers & More Monday, 7 Apr 2008 | 7:03 PM ET

    In Monday’s Web Extra, the traders reveal how to play Novartis, Citigroup and the solar sector.

  • Novartis to Buy Nestle's 25% Stake in Alcon Monday, 7 Apr 2008 | 12:21 PM ET

    Novartis has agreed to buy Nestle AG's percent stake in U.S. company Alcon in a deal worth up to $39 billion to boost its eye care business, the Swiss drugmaker said on Monday.

  • Economy Fears Knock Down Dow Thursday, 28 Feb 2008 | 6:27 PM ET

    Slowing economic growth and rising oil prices pushed The Dow lower Thursday. What's the word on the Street?

  • The 'Nifty 50': Rebound Stocks (Pt.3) Wednesday, 13 Feb 2008 | 2:04 PM ET

    When the economy rebounds, where's your portfolio going to be? UBS says that's a question to answer right now. The bank released what it calls its "'New' Nifty Fifty," a list of 50 companies from around the world that can use today's troubling market conditions to position themselves to thrive when the economy rebounds. (PART 3)

  • Pharma Analyst: Stocks Healthy Despite Bad News Thursday, 17 Jan 2008 | 3:55 PM ET
    Eli Lilly

    For the second time this week, big pharma is taking a beating from critical reports about medications. This time, it's antidepressants. But one analyst thinks the drag on shares is overdone -- and names "exciting" pharma stocks.

  • Novartis Boosts Shareholder Return as Profit Sinks Thursday, 17 Jan 2008 | 12:11 PM ET

    Swiss drug maker Novartis said Thursday its fourth-quarter profit fell sharply, mainly due to restructuring costs, but that it would increase returns to shareholders with a new buyback program and an increase to its dividend.

  • EU Raids Drug Companies in Broad Inquiry Wednesday, 16 Jan 2008 | 10:20 AM ET

    The European Commission raided some of the world's largest drugmakers on Wednesday, launching a broad investigation into whether they made illegal deals or abused patents to limit competition and harm consumers.

  • The Latest Picks That Paid Friday, 11 Jan 2008 | 7:12 PM ET
    Quicker Ticker

    Our traders are good - but you knew that! Check out their latest picks that paid.

  • Novartis Cuts, While Biogen Idec Cuts And Runs Thursday, 13 Dec 2007 | 4:06 PM ET
    Novartis

    Novartis is the latest company to brand its downsizing, cost-cutting campaign. The Swiss drugmaker is calling its initiative, "Forward". It's not an acronym. So, "Forward" means Novartis is going to try to save $1.6 billion in 2010 and get rid of 2,500 employees. Although I don't think "Forward" is the word which begins with "f" that the affected workers would use to describe the initiative.

  • Novartis Plans Restructuring, Job Cuts: WSJE Tuesday, 11 Dec 2007 | 3:50 AM ET

    Novartis plans a restructuring that will result in job cuts and the removal of several layers of management, according to an interview with CEO Daniel Vasella in the Wall Street Journal Europe.

  • America on Sale Monday, 10 Dec 2007 | 7:32 PM ET

    The trade as foreign firms rush to snap up American companies. Who will be targeted next by foreign buyers with a strong currency on their side?

  • Novartis Diabetes Drug Faces Further Delays Tuesday, 6 Nov 2007 | 3:44 AM ET
    Novartis

    Novartis has found safety problems in higher doses of its key Galvus diabetes drug and will revise prescribing recommendations before launching in Europe.

Most Popular Video

Wednesday, 23 Apr 2014 | 11:30 AM ET

Saving for retirement is about to get a whole lot more complicated. CNBC's Allison Linn reports on the "new normal" that may mean those planning to retire in 20-25 years may have to get used to a slightly lower standard of living than in the pension heyday.

Wednesday, 23 Apr 2014 | 11:00 AM ET

An 11th person was arrested yesterday in connection with a Philadelphia area drug ring where police say high school and college students were the targets.

Wednesday, 23 Apr 2014 | 10:17 AM ET

Former Apple CEO John Sculley, discusses Apple innovation and if the DNA of Apple has changed under CEO Tim Cook. Sculley also weighs in on earnings expectations for the tech giant.